ALAB Stock Jumps As RBC Hikes Price Target On AI Demand

Astera Labs Inc. stocks have been trading up by 14.28 percent amid bullish sentiment on its AI infrastructure leadership.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading ALAB

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

RBC expects Astera Labs to benefit from Amazon’s expanded Anthropic deal via its Scorpio X switches ramping for Trainium3 racks in Q3, driving revenue growth in H2 and beyond.
RBC sees additional long-term upside for Astera Labs from UALink and NVLink Fusion products at AWS and other hyperscalers.
RBC reiterates its Outperform rating on Astera Labs and raises its price target from $225 to $250.

Live Update At 12:32:37 EDT: On Wednesday, May 20, 2026 Astera Labs Inc. stock [NASDAQ: ALAB] is trending up by 14.28%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Astera Labs Inc. (ALAB) has been trading like a classic momentum AI name. Over the past several weeks, ALAB has ripped from a close of $183.31 on 2026/04/28 to $279.06 on 2026/05/20. That’s a big-time trend move, and traders are clearly leaning bullish.

On the daily chart, ALAB has put in a series of higher lows from the $180s, then the $190s, then the low $200s, with volume and range expanding as it pushed into the $250–$280 zone. Intraday on 2026/05/20, ALAB opened near $252 and never broke the premarket lows, grinding up through $260 and holding above $270 for most of the session. That price action shows steady dip buying rather than wild, one-and-done spikes.

More Breaking News

Fundamentals back up the excitement. ALAB just printed quarterly revenue of about $308.4M with gross margin near 75.7%, which is elite for a hardware-focused name. Net income of roughly $80.3M and EBITDA around $78.3M show the business is already profitable, not just a story. At the same time, ALAB trades at a rich price-to-sales multiple near 39.8 and a P/E above 150, so the market is pricing in heavy AI growth. For traders, that combination — strong margins and high expectations — means ALAB can move fast in both directions when headlines hit.

Why Traders Are Watching ALAB

ALAB is sitting right in the middle of the AI infrastructure trade, and the latest Wall Street call only poured more fuel on the fire. RBC reaffirmed its Outperform rating on Astera Labs Inc. and pushed its price target from $225 to $250. The key reason: ALAB’s role in Amazon Web Services’ next leg of AI buildout tied to Anthropic.

RBC expects Astera Labs to benefit as its Scorpio X switches ramp into Amazon’s Trainium3 racks starting in Q3. For traders, that’s important. It ties ALAB’s revenue path directly to a concrete AI deployment schedule, not just vague “AI opportunity” talk. The firm is basically saying: second half of the year is when the ALAB story hits the accelerator.

RBC also sees extra long-term upside from UALink and NVLink Fusion products at AWS and other hyperscalers. That implies ALAB is not just a one-off supplier but a key player in the high-speed interconnect layer that all major AI data centers need. When hyperscalers standardize around a vendor’s components, revenue can become more repeatable — and market share can snowball.

Short term, this kind of bullish call helps explain why ALAB has ripped from the low $200s to near $280. Traders are front-running that H2 ramp, using every dip into support as a chance to reload. But that same expectation also raises the bar: if ALAB’s future updates show any delay in Trainium3 or slower hyperscaler adoption, the stock can give back gains fast. Active traders in ALAB need to track Amazon, Anthropic, and data center AI capex closely, because that’s now the heartbeat of this chart.

Conclusion

Astera Labs Inc. sits at a crucial junction of AI hardware and cloud demand, and traders know it. The latest numbers show ALAB generating strong revenue, fat gross margins, and solid free cash flow around $67.0M last quarter. The balance sheet carries no long-term debt, with a current ratio above 10, which gives Astera Labs room to keep investing in new products without stressing the cash position.

Layer on top of that the RBC call: an Outperform rating, a higher $250 price target, and a clear thesis built on Amazon’s expanded Anthropic deal and Trainium3 racks. That connects the ALAB story directly to one of the biggest AI spending pipelines in the market. As long as hyperscalers keep racing to build AI clusters, traders will keep scanning ALAB for breakouts, pullbacks to key moving averages, and high-volume trend days.

Still, the rich valuation on ALAB means there is very little room for disappointment. Any wobble in AI capex or product rollout news can flip momentum traders from buyers to fast sellers. That’s why this name lines up with what Tim Sykes and his community teach all the time: “The trend is your friend, but only if you respect the risks and cut losses quickly.” And it also reinforces the daily discipline message that sits at the core of serious trading education. As Tim Bohen, lead trainer with StocksToTrade says, “A consistent trading routine beats sporadic action every time. Show up daily, and you’ll start to see the patterns others miss.” For traders using ALAB as an AI leverage play, the message is clear — ride the momentum, but stay disciplined every single day.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!